HRAS and head and neck squamous cell carcinoma: Gal1 increases H-Ras-driven MAPK output, and its elevated expression correlates with poorer survival in HRAS mutant cancers, such as head and neck squamous cell carcinoma, which frequently displays elevated Gal1 levels22,29 (Supplementary Fig. 2a).